health
AstraZeneca CEO says AI is reshaping drug development
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
TL;DR
- AI improves productivity in drug development by enabling faster and smarter medicine design.
- Practical applications of AI are evident across drug discovery and development stages.
- AI helps in identifying new drug targets and optimizing molecular design.
- AI aids in predicting potential side effects of drug molecules.
- Partnerships with AI companies like Tempus AI help analyze data for better decision-making.
- AI models are used to analyze clinical and laboratory data to predict the success probability of Phase 3 trials.
- Increasing the probability of success in trials leads to enormous productivity improvements, especially given the high costs of drug development.